Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Liver Transplantation

Free Subscription Articles published in Transpl Int Retrieve available abstracts of 89 articles: HTML format Text format

Single Articles

May 2019
1. LLADO L, Ramos E, Bravo A, Baliellas C, et al
   Short and long-term outcomes of arterial reconstruction on recipient splenic artery in adult liver transplantation. Single-center prospective study 25 years after first description.
   Transpl Int. 2019 May 2. doi: 10.1111/tri.13447.
   PubMed     Text format     Abstract available
   
   
   
2. BACCARANI U, Pravisani R, Isola M, Mocchegiani F, et al
   Early post-liver transplant surgical morbidity in HIV infected recipients: risk factor for overall survival? A nationwide retrospective study.
   Transpl Int. 2019 May 2. doi: 10.1111/tri.13446.
   PubMed     Text format     Abstract available
   
   
   
3. COMPAGNON P, Toso C
   Selective retransplantation after late hepatic artery thrombosis.
   Transpl Int. 2019;32:470-472.
   PubMed     Text format    
   
   
   April 2019
4. ONISCU GC
   '5-5-500' - yet another extended criteria for HCC or a truly innovative development?
   Transpl Int. 2019;32:353-355.
   PubMed     Text format    
   
   
   March 2019
5. BURRA P, Ferrarese A
   Health-related Quality of Life in Liver Transplantation: Another Step Forward.
   Transpl Int. 2019 Mar 29. doi: 10.1111/tri.13435.
   PubMed     Text format     Abstract available
   
   
   
6. ARORA SS, Axley P, Ahmed Z, Satapathy S, et al
   Decreasing Frequency and Improved Outcomes of Hepatitis C Related Liver Transplantation in the Era of Direct Acting Antivirals.
   Transpl Int. 2019 Mar 13. doi: 10.1111/tri.13424.
   PubMed     Text format     Abstract available
   
   
   
7. PRATSCHKE S, Bender A, Angele M
   Response to Ghinolfi et al.
   Transpl Int. 2019;32:336-337.
   PubMed     Text format    
   
   
   February 2019
8. TINTI F, Mitterhofer AP, Umbro I, Nightingale P, et al
   Combined Liver-Kidney Transplantation (CLKT) versus Liver Transplant alone (LTA) based on KDIGO stratification of estimated glomerular filtration rate (eGFR): Data from the United Kingdom Transplant Registry - a retrospective cohort study.
   Transpl Int. 2019 Feb 21. doi: 10.1111/tri.13413.
   PubMed     Text format     Abstract available
   
   
   
9. MCLEAN KA, Drake TM, Sgro A, Camilleri-Brennan J, et al
   The effect of liver transplantation on patient-centred outcomes: A propensity-score matched analysis.
   Transpl Int. 2019 Feb 21. doi: 10.1111/tri.13416.
   PubMed     Text format     Abstract available
   
   
   
10. MOON DB, Lee SG, Hwang S, Ahn CS, et al
    Splenic Devascularization Can Replace Splenectomy During Adult Living Donor Liver Transplantation - a historical cohort study.
    Transpl Int. 2019 Feb 3. doi: 10.1111/tri.13405.
    PubMed     Text format     Abstract available
    
    
    January 2019
11. WANG Y, Keinonen A, Koskenmies S, Pitkanen S, et al
    Occurrence of newly discovered human polyomaviruses in skin of liver transplant recipients and their relation with SCC in situ and actinic keratosis.
    Transpl Int. 2019 Jan 10. doi: 10.1111/tri.13397.
    PubMed     Text format     Abstract available
    
    
    December 2018
12. CAPELLI R, Allard MA, Ciacio O, Pittau G, et al
    Late hepatic artery thrombosis after liver transplantation: which strategy?
    Transpl Int. 2018 Dec 23. doi: 10.1111/tri.13394.
    PubMed     Text format     Abstract available
    
    
    
13. SHIMAMURA T, Akamatsu N, Fujiyoshi M, Kawaguchi A, et al
    Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule.
    Transpl Int. 2018 Dec 17. doi: 10.1111/tri.13391.
    PubMed     Text format     Abstract available
    
    
    November 2018
14. ESHMUMINOV D, Leoni F, Schneider MA, Becker D, et al
    Reply to "Ex situ normothermic machine perfusion of donor livers using a haemoglobin-based oxygen carrier: a viable alternative to red blood cells".
    Transpl Int. 2018;31:1283-1284.
    PubMed     Text format    
    
    
    
15. DE VRIES Y, van Leeuwen OB, Matton APM, Fujiyoshi M, et al
    Ex situ normothermic machine perfusion of donor livers using a haemoglobin-based oxygen carrier: a viable alternative to red blood cells.
    Transpl Int. 2018;31:1281-1282.
    PubMed     Text format    
    
    
    
16. RAJALINGAM R, Reddy MS, Rela M
    Intraoperative cholangiogram to delineate caudate biliary anatomy in donor hepatectomy: Are we shooting for trouble?
    Transpl Int. 2018;31:1285-1286.
    PubMed     Text format    
    
    
    October 2018
17. D'AMICO G, Hassan A, DiagoUso T, Lindenmeyer CC, et al
    Renoportal Anastomosis in Liver Transplantation and Its Impact on Patient Outcomes: A Systematic Literature Review.
    Transpl Int. 2018 Oct 25. doi: 10.1111/tri.13368.
    PubMed     Text format     Abstract available
    
    
    
18. GHINOLFI D, Lai Q, De Simone P
    Reply to "Association between donor age and risk of graft failure after liver transplantation: an analysis of the eurotransplant database - A retrospective cohort study".
    Transpl Int. 2018 Oct 23. doi: 10.1111/tri.13367.
    PubMed     Text format     Abstract available
    
    
    
19. GAY S, Levrat A, Dorez D
    Controlled donation after circulatory death in France: first results of a nonuniversity pilot centre.
    Transpl Int. 2018;31:1178-1180.
    PubMed     Text format    
    
    
    September 2018
20. PRATSCHKE S, Bender A, Boesch F, Andrassy J, et al
    Association between donor age and risk of graft failure after liver transplantation: An analysis of the Eurotransplant database - a retrospective cohort study.
    Transpl Int. 2018 Sep 27. doi: 10.1111/tri.13357.
    PubMed     Text format     Abstract available
    
    
    
21. ADAM R, Karam V, Cailliez V, O Grady JG, et al
    2018 annual report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation.
    Transpl Int. 2018 Sep 26. doi: 10.1111/tri.13358.
    PubMed     Text format     Abstract available
    
    
    
22. ZANETTO A, Rodriguez-Kastro KI, Germani G, Ferrarese A, et al
    Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis.
    Transpl Int. 2018 Sep 19. doi: 10.1111/tri.13353.
    PubMed     Text format     Abstract available
    
    
    
23. GHINOLFI D, Tincani G, Rreka E, Roffi N, et al
    Dual aortic and portal perfusion at procurement prevents ischemic-type biliary lesions in liver transplantation when using octogenarian donors: a retrospective cohort study.
    Transpl Int. 2018 Sep 10. doi: 10.1111/tri.13342.
    PubMed     Text format     Abstract available
    
    
    August 2018
24. BECHSTEIN W, Schnitzbauer A
    Do you really know what you get: the benefits and doubts of Domino Liver Transplantation.
    Transpl Int. 2018 Aug 28. doi: 10.1111/tri.13339.
    PubMed     Text format     Abstract available
    
    
    
25. TOSO C, Meeberg G, Andres A, Shore C, et al
    Downstaging prior to liver transplantation for hepatocellular carcinoma: advisable but at the price of an increased risk of cancer recurrence - a retrospective study.
    Transpl Int. 2018 Aug 28. doi: 10.1111/tri.13337.
    PubMed     Text format     Abstract available
    
    
    
26. PARK J, Choi GS, Gwak MS, Ko SJ, et al
    A retrospective analysis of re-exploration after living donor right lobe liver transplantation: incidence, causes, outcomes, and risk factors.
    Transpl Int. 2018 Aug 25. doi: 10.1111/tri.13335.
    PubMed     Text format     Abstract available
    
    
    
27. SCHREIBER PW, Bischoff-Ferrari HA, Boggian K, van Delden C, et al
    Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study.
    Transpl Int. 2018 Aug 12. doi: 10.1111/tri.13328.
    PubMed     Text format     Abstract available
    
    
    
28. VOLLMAR J, Ch Schmid J, Hoppe-Lotichius M, Barreiros AP, et al
    Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation.
    Transpl Int. 2018 Aug 8. doi: 10.1111/tri.13326.
    PubMed     Text format     Abstract available
    
    
    July 2018
29. GAVRIILIDIS P, Tobias A, Sutcliffe RP, Roberts KJ, et al
    Survival following right lobe split graft, living- and deceased-donor liver transplantation in adult patients: a systematic review and network meta-analysis.
    Transpl Int. 2018 Jul 17. doi: 10.1111/tri.13317.
    PubMed     Text format     Abstract available
    
    
    
30. JOO DJ, Song SH, Han DH, Park MS, et al
    First Report of a Living Liver Graft in Combined Lung and Liver Transplantation.
    Transpl Int. 2018 Jul 6. doi: 10.1111/tri.13316.
    PubMed     Text format     Abstract available
    
    
    
31. CASCIATO P, Ambrosi N, Caro F, Vazquez M, et al
    alpha-Lipoic Acid Reduces Post-Reperfusion Syndrome in Human Liver Transplantation - a pilot study.
    Transpl Int. 2018 Jul 5. doi: 10.1111/tri.13314.
    PubMed     Text format     Abstract available
    
    
    June 2018
32. BECKMANN S, Denhaerynck K, Stampf S, Saigi-Morgui N, et al
    New-onset obesity after liver transplantation-outcomes and risk factors: the Swiss Transplant Cohort Study.
    Transpl Int. 2018 Jun 21. doi: 10.1111/tri.13308.
    PubMed     Text format     Abstract available
    
    
    
33. GEYER ED, Burrier C, Tumin D, Hayes D Jr, et al
    Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Transpl Int. 2018 Jun 15. doi: 10.1111/tri.13291.
    PubMed     Text format     Abstract available
    
    
    
34. VINAIXA C, Selzner N, Berenguer M
    Fat and liver transplantation: clinical implications.
    Transpl Int. 2018 Jun 8. doi: 10.1111/tri.13288.
    PubMed     Text format     Abstract available
    
    
    
35. QUINTINI C, Diago Uso T, Fujiki M, Eghtesad B, et al
    Liver "lobe neutrality" in the era of donor safety. Could "safe" be safer?
    Transpl Int. 2018;31:588-589.
    PubMed     Text format    
    
    
    
36. TAKAHASHI Y, Matsuura T, Yoshimaru K, Yanagi Y, et al
    Liver graft-to-spleen volume ratio as a useful predictive factor of the early graft function in children and young adults transplanted for biliary atresia: a retrospective study.
    Transpl Int. 2018;31:620-628.
    PubMed     Text format     Abstract available
    
    
    
37. GOJA S, Yadav SK, Saigal S, Soin AS, et al
    Right lobe donor hepatectomy: is it safe? A retrospective study.
    Transpl Int. 2018;31:600-609.
    PubMed     Text format     Abstract available
    
    
    May 2018
38. SANADA Y, Katano T, Hirata Y, Yamada N, et al
    Interventional radiology treatment for vascular and biliary complications following pediatric living donor liver transplantation.
    Transpl Int. 2018 May 31. doi: 10.1111/tri.13285.
    PubMed     Text format     Abstract available
    
    
    
39. MAKKI K, Chorasiya V, Srivastava A, Singhal A, et al
    Analysis of caudate lobe biliary anatomy and its implications in living donor liver transplantation - a single centre prospective study.
    Transpl Int. 2018 May 2. doi: 10.1111/tri.13272.
    PubMed     Text format     Abstract available
    
    
    April 2018
40. LOH PS, Gilder F, Klinck J
    Intra-operative cell salvage and sickle cell trait in liver transplantation: time to re-consider?
    Transpl Int. 2018 Apr 19. doi: 10.1111/tri.13268.
    PubMed     Text format     Abstract available
    
    
    March 2018
41. MANZIA TM, Lai Q, Iesari S, Perera MTPR, et al
    Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multi centre cohort study.
    Transpl Int. 2018 Mar 23. doi: 10.1111/tri.13153.
    PubMed     Text format     Abstract available
    
    
    
42. ANGELICO R, Nardi A, Adam R, Nadalin S, et al
    Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry (ELTR).
    Transpl Int. 2018 Mar 5. doi: 10.1111/tri.13147.
    PubMed     Text format     Abstract available
    
    
    
43. AGUILERA V, Di Maira T, Conde I, Fornes-Ferrer V, et al
    Cytomegalovirus reactivation in liver transplant recipients due to HCV cirrhosis is associated with higher cardiovascular risk.
    Transpl Int. 2018 Mar 1. doi: 10.1111/tri.13145.
    PubMed     Text format     Abstract available
    
    
    February 2018
44. BLOK JJ, de Boer JD, Putter H, Rogiers X, et al
    The center effect in liver transplantation in the Eurotransplant region.
    Transpl Int. 2018 Feb 6. doi: 10.1111/tri.13129.
    PubMed     Text format     Abstract available
    
    
    
45. CEULEMANS LJ, Vos R, Neyrinck A, Pirenne J, et al
    Liver-first versus lung-first: a new dilemma in combined organ transplantation.
    Transpl Int. 2018;31:230-231.
    PubMed     Text format    
    
    
    January 2018
46. POMMERGAARD HC, Rostved AA, Adam R, Thygesen LC, et al
    Locoregional treatments before liver transplantation for hepatocellular carcinoma: A study from the European Liver Transplant Registry.
    Transpl Int. 2018 Jan 30. doi: 10.1111/tri.13123.
    PubMed     Text format     Abstract available
    
    
    
47. BIELEN R, Robaeys G, Schelfhout S, Monbaliu D, et al
    Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues for patients at risk for renal failure after liver transplantation.
    Transpl Int. 2018 Jan 23. doi: 10.1111/tri.13112.
    PubMed     Text format     Abstract available
    
    
    November 2017
48. SERPER M, Reese P, Patzer R, Levitsky J, et al
    The Prevalence, Risk Factors, and Outcomes of Medication Tradeoffs in Kidney and Liver Transplant Recipients: A Pilot Study.
    Transpl Int. 2017 Nov 25. doi: 10.1111/tri.13098.
    PubMed     Text format     Abstract available
    
    
    
49. GOET JC, Hansen BE, Tieleman M, van Hoek B, et al
    Current policy for allocation of donor livers in the Netherlands advantages Primary Sclerosing Cholangitis patients on the liver transplantation waiting list - a retrospective study.
    Transpl Int. 2017 Nov 18. doi: 10.1111/tri.13097.
    PubMed     Text format     Abstract available
    
    
    
50. KARTHIK SV, Quak SH, Aw MM
    Endoscopic retrograde cholangio-pancreatography in the management of biliary complications after Paediatric liver transplantation.
    Transpl Int. 2017 Nov 11. doi: 10.1111/tri.13091.
    PubMed     Text format     Abstract available
    
    
    
51. LANDI F, de'Angelis N, Sepulveda A, Martinez-Perez A, et al
    Endoscopic treatment of anastomotic biliary stricture after adult deceased donor liver transplantation with multiple plastic stents versus self-expandable metal stents: a systematic review and meta-analysis.
    Transpl Int. 2017 Nov 1. doi: 10.1111/tri.13089.
    PubMed     Text format     Abstract available
    
    
    September 2017
52. VAN VUGT JLA, Buettner S, Alferink LJM, Bossche N, et al
    Low Skeletal Muscle Mass is Associated with Increased Hospital Costs in Patients with Cirrhosis Listed for Liver Transplantation.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13048.
    PubMed     Text format     Abstract available
    
    
    
53. GILBO N, Van Praet L, Jochmans I, Sainz-Barriga M, et al
    Preoperative Trans-Catheter Arterial Chemo Embolization Increases Hepatic Artery Thrombosis after Liver Transplantation - a retrospective study.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13046.
    PubMed     Text format     Abstract available
    
    
    August 2017
54. QUINTERO J, Juamperez J, Ortega J, Molino JA, et al
    Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients.
    Transpl Int. 2017 Aug 21. doi: 10.1111/tri.13037.
    PubMed     Text format     Abstract available
    
    
    
55. PEZZATI D, Hassan A, Buccini L, Liu Q, et al
    Liver transplantation with geriatric liver allograft in the US: A matter of epidemiology or of outcome requirements?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13013.
    PubMed     Text format     Abstract available
    
    
    July 2017
56. ARAVINTHAN AAD, Barbas AS, Doyle AC, Tazari M, et al
    Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
    Transpl Int. 2017 Jul 7. doi: 10.1111/tri.13008.
    PubMed     Text format     Abstract available
    
    
    June 2017
57. SATAPATHY SK, Jiang Y, Eason JD, Kedia SK, et al
    Cardiovascular Mortality among Liver Transplant Recipients with Nonalcoholic Steatohepatitis (NASH) in the United States.
    Transpl Int. 2017 Jun 16. doi: 10.1111/tri.13001.
    PubMed     Text format     Abstract available
    
    
    
58. WHITEHOUSE GP, Hope A, Sanchez-Fueyo A
    Regulatory T Cell Therapy in Liver Transplantation.
    Transpl Int. 2017 Jun 13. doi: 10.1111/tri.12998.
    PubMed     Text format     Abstract available
    
    
    
59. SALCEDO M, Prieto M, Castells L, Pascasio JM, et al
    Efficacy and safety of daclatasvir-based antiviral therapy in HCV recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multi-centre cohort study.
    Transpl Int. 2017 Jun 13. doi: 10.1111/tri.12999.
    PubMed     Text format     Abstract available
    
    
    
60. TAKAHASHI K, Nagai S, Puchakayala KG, Safwan M, et al
    Prediction of Biliary Anastomotic Stricture after Deceased Donor Liver Transplantation: The Impact of Platelet Counts.
    Transpl Int. 2017 Jun 12. doi: 10.1111/tri.12996.
    PubMed     Text format     Abstract available
    
    
    May 2017
61. BADAWY A, Hamaguchi Y, Seo S, Kaido T, et al
    Evaluation of Safety of Concomitant Splenectomy in Living Donor Liver Transplantation.
    Transpl Int. 2017 May 17. doi: 10.1111/tri.12985.
    PubMed     Text format     Abstract available
    
    
    
62. METSELAAR HJ, van den Berg A, Coenraad MJ
    Why we need fairer allocation rules for patients with hepatocellular carcinoma awaiting a liver transplant.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12980.
    PubMed     Text format     Abstract available
    
    
    April 2017
63. ALVER SK, Lorenz DJ, Washburn K, Marvin MR, et al
    Comparison of two equivalent MELD scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12967.
    PubMed     Text format     Abstract available
    
    
    
64. ALFERINK LJ, Oey RC, Hansen BE, Polak WG, et al
    The impact of infections on delisting patients from the liver transplantation waiting list.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12965.
    PubMed     Text format     Abstract available
    
    
    
65. YASSEN AM, Elsarraf WR, Elmorshedi MA, Abdel Wahab M, et al
    Short-term effects of extracorporeal graft rinse versus circulatory graft rinse in living donor liver transplantation. A Prospective Randomized Controlled Trial.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12968.
    PubMed     Text format     Abstract available
    
    
    
66. PEZZATI D, Ghinolfi D, Lai Q, Cirillo G, et al
    Use of donors with genitourinary malignancies for liver transplantation: A calculated risk?
    Transpl Int. 2017 Apr 8. doi: 10.1111/tri.12962.
    PubMed     Text format     Abstract available
    
    
    March 2017
67. SGARABOTTO D, Fasolato S, Vianello F, Vittadello F, et al
    Antibiotic prophylaxis for preventing post orthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid?
    Transpl Int. 2017 Mar 23. doi: 10.1111/tri.12955.
    PubMed     Text format     Abstract available
    
    
    
68. HARRIES L, Schrem H, Stahmeyer JT, Krauth C, et al
    High Resource Utilization in Liver Transplantation - How Strongly differ Costs between the Care Sectors and What are the Main Cost Drivers?
    Transpl Int. 2017 Mar 11. doi: 10.1111/tri.12950.
    PubMed     Text format     Abstract available
    
    
    
69. ROLLER J, Glanemann M
    Keep the pressure! Correlation of hemodynamic instability after reperfusion and severity of acute kidney injury following liver transplantation.
    Transpl Int. 2017 Mar 7. doi: 10.1111/tri.12948.
    PubMed     Text format     Abstract available
    
    
    
70. DE BOER JD, Kopp WH, Ooms K, Haase-Kromwijk BJ, et al
    Abdominal organ procurement in the Netherlands - an analysis of quality and clinical impact.
    Transpl Int. 2017;30:288-294.
    PubMed     Text format     Abstract available
    
    
    February 2017
71. SCHNITZBAUER AA, Bechstein WO
    Equitable distribution in rare indications for liver transplantation: the dilemma of the too small tablecloth continues!
    Transpl Int. 2017 Feb 22. doi: 10.1111/tri.12942.
    PubMed     Text format     Abstract available
    
    
    
72. GROSSI PA
    Liver Transplantation from donors with positive blood cultures: increased risk of graft failure or opportunity to expand the donor pool?
    Transpl Int. 2017 Feb 20. doi: 10.1111/tri.12939.
    PubMed     Text format     Abstract available
    
    
    January 2017
73. BURRA P, Zanetto A
    Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation.
    Transpl Int. 2017 Jan 19. doi: 10.1111/tri.12917.
    PubMed     Text format     Abstract available
    
    
    
74. DE BOER JD, Koopman JJ, Metselaar HJ, Braat AE, et al
    Liver transplantation with geriatric liver allografts: the current situation in Eurotransplant.
    Transpl Int. 2017 Jan 6. doi: 10.1111/tri.12914.
    PubMed     Text format     Abstract available
    
    
    
75. D'AGNOLO HM, Kievit W, van Munster KN, van der Laan JJ, et al
    Center is an important indicator for choice of invasive therapy in polycystic liver disease.
    Transpl Int. 2017;30:76-82.
    PubMed     Text format     Abstract available
    
    
    December 2016
76. HERZER K, Welzel TM, Spengler U, Hinrichsen H, et al
    Real-World Experience With Daclatasvir Plus Sofosbuvir +/- Ribavirin for Post-Liver Transplant HCV Recurrence and Severe Liver Disease.
    Transpl Int. 2016 Dec 24. doi: 10.1111/tri.12910.
    PubMed     Text format     Abstract available
    
    
    November 2016
77. DE MARTIN E, Antonini TM, Coilly A, Pittau G, et al
    HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12898.
    PubMed     Text format     Abstract available
    
    
    
78. O'LEARY JG, Fontana RJ, Brown K, Burton JR Jr, et al
    Efficacy and Safety of Simeprevir and Sofosbuvir With and Without Ribavirin in Subjects With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant: The Randomized GALAXY Study.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12896.
    PubMed     Text format     Abstract available
    
    
    
79. HUAMAN MA, Vilchez V, Mei X, Shah MB, et al
    Decreased Graft Survival in Liver Transplant Recipients of Donors with Positive Blood Cultures: A review of the UNOS dataset.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12900.
    PubMed     Text format     Abstract available
    
    
    
80. KALISVAART M, de Haan JE, Hesselink DA, Polak WG, et al
    The Postreperfusion Syndrome Is Associated With Acute Kidney Injury Following Donation After Brain Death Liver Transplantation.
    Transpl Int. 2016 Nov 19. doi: 10.1111/tri.12891.
    PubMed     Text format     Abstract available
    
    
    October 2016
81. VOUTILAINEN SH, Kosola SK, Tervahartiala TI, Sorsa TA, et al
    Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipients.
    Transpl Int. 2016 Oct 23. doi: 10.1111/tri.12879.
    PubMed     Text format     Abstract available
    
    
    
82. SINGAL AK, Fang X, Kaif M, Hasanin M, et al
    Primary Biliary Cirrhosis Has High Wait List Mortality Among Patients Listed For Liver Transplantation.
    Transpl Int. 2016 Oct 18. doi: 10.1111/tri.12877.
    PubMed     Text format     Abstract available
    
    
    
83. STINE JG, Argo CK, Pelletier SJ, Maluf DG, et al
    Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.
    Transpl Int. 2016 Oct 6. doi: 10.1111/tri.12855.
    PubMed     Text format     Abstract available
    
    
    September 2016
84. NEVIERE R, Trinh-Duc P, Hulo S, Edme JL, et al
    Predictive value of exhaled nitric oxide and aerobic capacity for sepsis complications after liver transplantion.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12861.
    PubMed     Text format     Abstract available
    
    
    May 2016
85. BEINHARDT S, Al Zoairy R, Ferenci P, Kozbial K, et al
    DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and post kidney transplantation setting.
    Transpl Int. 2016 May 20. doi: 10.1111/tri.12799.
    PubMed     Text format     Abstract available
    
    
    April 2016
86. BRANDL A, Stolzlechner P, Eschertzhuber S, Aigner F, et al
    Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
    Transpl Int. 2016;29:471-82.
    PubMed     Text format     Abstract available
    
    
    February 2016
87. ELDEEN FZ, Mourad MM, Bhandari M, Roll G, et al
    Accepting multiple simultaneous liver offers does not negatively impact transplant outcomes.
    Transpl Int. 2016;29:227-33.
    PubMed     Text format     Abstract available
    
    
    January 2016
88. ZHONG Z, Ye S, Xiong Y, Wu L, et al
    Decreased expression of mitochondrial aldehyde dehydrogenase-2 induces liver injury via activation of the mitogen-activated protein kinase pathway.
    Transpl Int. 2016;29:98-107.
    PubMed     Text format     Abstract available
    
    
    
89. PANDANABOYANA S, Longbotham D, Hostert L, Attia M, et al
    Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.
    Transpl Int. 2016;29:73-80.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: